OMNY Health Poster:

Using Natural Language Processing to Identify Adverse Drug Events of Angiotensin Converting Enzyme Inhibitors

Register below to see OMNY Health data in action!

On June 9-11, 2021, this poster was on display at the virtual International Forum on Quality and Safety in Healthcare EUROPE. 

Register to View the Poster

What is the Objective of this Poster?

OMNY Health On-Demand Webinar: Health Data Partnerships Innovate Rare Disease Research
  • Validate an end-to-end adverse drug event (ADE) detection system from the licensed software package Spark NLP for Healthcare (John Snow Labs, Inc)
  • Assess results against known ADEs of angiotensin converting enzyme inhibitors (ACE-I; a drug class for treatnment of renal failure, hypertension, and heart disease)

Check Out More Events & Webinars…

Contact Us

Reach out to us for more information about OMNY Health, our platform, and our mission.

Sign up for Our Newsletter

Sign up now to receive our newsletter in the future with OMNY Health updates and industry insights.

By continuing to use the site, you agree to the use of cookies. More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.